Literature DB >> 21274247

Prenatal diagnosis by amniocentesis and chorionic villus biopsy.

J L Reynolds.   

Abstract

Prenatal diagnosis forms only a small part of day-to-day family practice, but the techniques are of critical importance to couples at risk of having a child affected by genetic disorder. Second trimester amniocentesis will probably be replaced by first trimester chorionic villus biopsy and recombinant DNA technology, but the ethical and moral problems related to prenatal diagnosis are not so easily solved. Family physicians need to examine their own attitudes toward the handicapped before they offer counselling to couples at risk of bearing handicapped children. The controversy over abortion is central to the issue of prenatal diagnosis, and may only be resolved by development of prenatal treatments for certain genetic disorders. Sometimes the only thing we can offer patients is to be with them, in whatever their decisions bring.

Entities:  

Year:  1986        PMID: 21274247      PMCID: PMC2327586     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  8 in total

1.  Chorionic villus sampling. Evaluating safety and efficacy.

Authors:  B Modell
Journal:  Lancet       Date:  1985-03-30       Impact factor: 79.321

Review 2.  The reduction of anencephalic and spina bifida births by maternal serum alphafetoprotein screening.

Authors:  M A Ferguson-Smith
Journal:  Br Med Bull       Date:  1983-10       Impact factor: 4.291

3.  Effect of introducing antenatal diagnosis on reproductive behaviour of families at risk for thalassaemia major.

Authors:  B Modell; R H Ward; D V Fairweather
Journal:  Br Med J       Date:  1980-06-07

4.  Feasibility of prenatal diagnosis of beta-thalassaemia with synthetic DNA probes in two Mediterranean populations.

Authors:  S L Thein; J S Wainscoat; J M Old; M Sampietro; G Fiorelli; R B Wallace; D J Weatherall
Journal:  Lancet       Date:  1985-08-17       Impact factor: 79.321

5.  First trimester prenatal diagnosis and detection of carriers of haemophilia A using the linked DNA probe DX13.

Authors:  R M Winter; K Harper; E Goldman; R S Mibashan; R C Warren; C H Rodeck; R J Penketh; R H Ward; R M Hardisty; M E Pembrey
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-21

6.  Risks of midtrimester amniocentesis; assessment in 3000 pregnancies.

Authors:  N J Leschot; M Verjaal; P E Treffers
Journal:  Br J Obstet Gynaecol       Date:  1985-08

7.  Preventing the birth of infants with Down's syndrome: a cost-benefit analysis.

Authors:  S Hagard; F A Carter
Journal:  Br Med J       Date:  1976-03-27

8.  An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities.

Authors:  I R Merkatz; H M Nitowsky; J N Macri; W E Johnson
Journal:  Am J Obstet Gynecol       Date:  1984-04-01       Impact factor: 8.661

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.